LFMD Q3 2021 Earnings — LifeMD, Inc. Revenue & Financial Results | Market Cap Arena

LFMDLifeMD, Inc.

$200M

Q3 2021 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$25M+126.7% YoY

Gross Profit

$20M79.6% margin

Operating Income

-$13M-50.5% margin

Net Income

-$14M-57.5% margin

EPS (Diluted)

$-0.54

QoQ Revenue Growth

+11.8%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$8M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$16M

Total Liabilities

$31M

Stockholders' Equity

-$14M

Cash & Equivalents

$9M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$25M	$11M	+126.7%
Gross Profit	$20M	$9M	+112.8%
Operating Income	-$13M	-$21M	+38.7%
Net Income	-$14M	-$21M	+30.4%

Revenue Segments

Telehealth Revenue Net

$19M62%

Work Simpli Revenue Net

$6M21%

Cost of Telehealth Revenue

$5M17%

Cost of Work Simpli Revenue

$127,1810%